Skip to main content
. Author manuscript; available in PMC: 2024 Aug 1.
Published in final edited form as: Lab Invest. 2023 May 12;103(8):100176. doi: 10.1016/j.labinv.2023.100176

Figure 5: HALO AI nuclear phenotyper illustrates heterogeneity in patient NSCLC samples.

Figure 5:

A) Representative human squamous cell carcinoma. B) Representative human adenocarcinoma. C) Proportions of the different cell types within the tumor micro-environment, SCC n=102, ADC n=83, ADSCC n=14, Poorly Differentiated n=17.